HATCH: Holistic Assessment of Tulsa Children's Health

Sponsor
University of Oklahoma (Other)
Overall Status
Recruiting
CT.gov ID
NCT04158089
Collaborator
Oklahoma Center for the Advancement of Science and Technology (Other)
160
1
2
17.3
9.2

Study Details

Study Description

Brief Summary

The primary goal of this study is to rapidly increase maternal-fetal bonding, a strong predictor of maternal health practices during pregnancy, through an intervention, BLOOM (Babies and Moms, connected by Love, Openness, and Opportunity). Specifically, the investigators will examine change in maternal-fetal bonding across pregnancy and implications for change in maternal smoking during pregnancy using a randomized clinical trial design in a longitudinal, multi-ethnic cohort study of 160 women (ages 18 or older) who are 12-16 weeks pregnant. Participants will be randomly assigned into one of two groups for the intervention; the control group will receive treatment as usual. Participants assigned to the treatment group will receive texted attachment/mindfulness exercises. Participants will complete an in-depth initial assessment that includes sociodemographic measures as well as a battery to capture maternal-fetal bonding and self-reported smoking. Pre- and post-tests will be used to assess maternal-fetal bonding and smoking before and after the intervention to allow for examination of change across pregnancy. The positive impacts of this work include information that will be used to reduce the impact of unintended pregnancy for adverse infant health outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Babies and Moms connected through Love, Openness, and Opportunity (BLOOM)
N/A

Detailed Description

Unintended pregnancy (unwanted and/or mistimed pregnancy) heightens the risk for adverse birth outcomes, including preterm birth and very low birth weight (< 1500 grams), which have significant public health costs. Despite decades spent attempting to reduce the proportion of pregnancies that are unintended, nearly half (45%) of all pregnancies are unintended. Among women living in poverty, rates of unintended pregnancy are considerably higher. In this study, investigators focus instead on the reduction of a risky maternal health practice associated with adverse birth outcomes that are more common when pregnancies are unintended: maternal prenatal smoking. The study focuses on rapidly increasing maternal-fetal bonding, a mediator of the relationship between unintended pregnancy and maternal health practices during pregnancy, through a recently piloted intervention, BLOOM (Babies and Moms, connected by Love, Openness, and Opportunity). Specifically, the investigators will examine change in maternal-fetal bonding across pregnancy and implications for change in maternal smoking during pregnancy. The proposed study will use a randomized clinical trial design in a longitudinal, multi-ethnic cohort study of 160 predominately low-income women (ages 18 or older) who are 12-16 weeks pregnant and planning to continue their pregnancies and be primary caregivers to their infants. Participants will be randomly assigned into one of two groups for the intervention; the control group will receive treatment as usual. Participants assigned to the treatment group will receive texted attachment/mindfulness exercises. Participants will complete an in-depth initial assessment that includes sociodemographic measures as well as a battery to capture maternal-fetal bonding and self-reported smoking. The 2-week intervention will be conducted within two weeks following Assessment 1. Participants will then be asked to complete a follow-up survey near the beginning of their 3rd trimester to assess maternal-fetal bonding and smoking to allow for examination of change across pregnancy. Impacts of prior interventions to reduce unintended pregnancy and its associated adverse infant outcomes have been modest; reducing the negative association between unintended pregnancy and adverse outcomes through enhancing maternal prenatal attachment makes this project highly significant. This project will be the first to target maternal-fetal bonding through the use of a cellphone-based intervention designed to increase feelings of bonding through attachment and mindfulness exercises, making it highly innovative. The positive impacts of this work include information that will be used to reduce the impact of unintended pregnancy for adverse infant health outcomes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
This intervention examines whether the use of texted attachment exercises to effectively increase maternal prenatal bonding.This intervention examines whether the use of texted attachment exercises to effectively increase maternal prenatal bonding.
Masking:
Double (Care Provider, Outcomes Assessor)
Masking Description:
Due to the behavioral design of the intervention, it is impossible to mask participants (who are asked to do tasks) or investigators (who train participants and contact them about tasks). However, care providers are not involved in the study, and the statistical analyses will be conducted with a de-identified data set.
Primary Purpose:
Prevention
Official Title:
Holistic Assessment of Tulsa Children's Health
Actual Study Start Date :
Dec 20, 2021
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: No intervention

Participants in the "No intervention" group will receive treatment (e.g., prenatal care) as usual.

Experimental: Attachment Exercises

Participants in the "Attachment Exercises" group will receive daily texts over the 2-week intervention period with activities to do from home that are designed to increase feelings of attachment (e.g., read a children's book aloud; sing a nursery rhyme; picture giving the baby a bath; tell the baby a story; etc.).

Behavioral: Babies and Moms connected through Love, Openness, and Opportunity (BLOOM)
Participants will be randomly assigned into one of two groups for the BLOOM intervention; the control group will receive treatment as usual. Participants assigned to the treatment group will receive texted attachment exercises to complete from home. The intervention will take place over a 2-week period. Participants in the "Attachment Exercises" group will receive a text every day with an activity designed to increase feelings of attachment (e.g., read a children's book; sign a nursery rhyme; picture giving your baby a baby; tell your baby a story, etc.).

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline Maternal-Fetal Attachment at 4 months [Through study completion, an average of 1 year]

    Maternal-Fetal Attachment Scale (MFAS) is a 24-item, Likert type, self-rated scale with five subscales (Cranley, 1981)

  2. Change from Baseline Self-Reported Smoking Status at 4 months [Through study completion, an average of 1 year]

    Survey questions asking about frequency, type (vaping vs. combustible); cannabis vs. tobacco; amount (relevant for vaping)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • At least 18 years of age

  • Between 12-16 weeks pregnant at the time of enrollment.

Exclusion Criteria:
  • Unable to communicate in either English or Spanish

  • Planning to either terminate the pregnancy or place the baby for adoption.

Contacts and Locations

Locations

Site City State Country Postal Code
1 OU Women's Health and Specialty Clinic Oklahoma City Oklahoma United States 73104

Sponsors and Collaborators

  • University of Oklahoma
  • Oklahoma Center for the Advancement of Science and Technology

Investigators

  • Principal Investigator: Karina M Shreffler, PhD, University of Oklahoma

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT04158089
Other Study ID Numbers:
  • HS1871
First Posted:
Nov 8, 2019
Last Update Posted:
Jan 11, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 11, 2022